KIA
MRTX

KCM Investment Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

KCM Investment Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,000
Closed -$930K – 414
2023
Q1 		$930K Buy
+25,000
New +$930K 0.04% 218